As of 2:30 PM on the 5th, Labgenomics is trading at 52,700 KRW, up 5.51% from the previous day. This represents a 126.67% increase compared to July 9. Labgenomics is known as a manufacturer of in vitro diagnostics and gene analysis services and products.
Today, foreigners have net sold 3,000 shares of Labgenomics, while institutions have net bought 28,000 shares, according to provisional data. Over the past five days, individual investors have net bought 121,083 shares, while foreigners and institutions have net sold 61,470 shares and 69,743 shares, respectively.
On July 30, Labgenomics made headlines in the market with a "5.8 billion KRW supply contract for COVID-19 diagnostic kits."

[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
